Moneycontrol
Get App
you are here: HomeNewsBusiness
Last Updated : Aug 04, 2019 02:10 PM IST | Source: PTI

Maharashtra govt to set up single-window clearance system for pharma companies

FDA Minister Jaykumar Rawal recently held meetings with representatives of the Indian Drug Manufacturing Association to understand why the pharma companies, for whom Maharashtra was earlier a preferred destination, shifted to Himachal Pradesh in recent years.

The Maharashtra government is planning to attract pharmaceutical companies to set up base in the state and has decided to set up a single-window system to grant them clearances and address their grievances.

Food and Drug Administration (FDA) Minister Jaykumar Rawal recently held meetings with representatives of the Indian Drug Manufacturing Association to understand why the pharma companies, for whom Maharashtra was earlier a preferred destination, shifted to Himachal Pradesh in recent years.

Earlier, around 3,000 pharma companies had their manufacturing units in Maharashtra. But gradually, majority of them shifted to Himachal Pradesh due to various sops offered there, Rawal told reporters during the weekend.

Close

"I found out during my meetings with the stakeholders that these companies face a big hurdle in getting environmental clearances. The FDA will set up a single-window clearance system to help in this matter," he said.

Rawal said there were plans to make Nagpur and Aurangabad as the 'pharma hubs' in the state.

In Nagpur, work is already in progress at MIHAN (Multi-modal International Cargo Hub and Airport at Nagpur), he noted.

"The focus will be on production of Ayurvedic medicines. There are plans to make a pharma hub between Aurangabad and Nashik along the Mumbai-Nagpur Samruddhi Corridor. Plans are also afoot to set up a world class lab at the pharma hubs," the minister said.

"We want to compete with China in the production of generic medicines," he further said.

The Indian pharma products have a good response in Europe, he said, adding that Bosnia is keen on a joint co- operation with Maharashtra in the pharma sector.

Subscribe to Moneycontrol Pro and gain access to curated markets data, trading recommendations, equity analysis, investment ideas, insights from market gurus and much more. Get Moneycontrol PRO for 1 year at price of 3 months at 289. Use code FREEDOM.
First Published on Aug 4, 2019 01:59 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant